# Oruka Therapeutics, Inc.: Form 8-K, filed Jul 9, 2024

- Company: [Oruka Therapeutics, Inc.](/companies/orka.md) (CIK 907654)
- Form: 8-K
- Filed: 2024-07-09
- Accepted by EDGAR: Jul 9, 2024, 17:01 ET
- Period: 2024-07-03
- Accession: 0001213900-24-060156
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/907654/000121390024060156/ea0209134-8k425_arcabio.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/907654/000121390024060156/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/907654/000121390024060156/ea0209134-8k425_arcabio.htm

Filed Jul 9, 2024.
Source: SEC EDGAR, the filing index for accession 0001213900-24-060156. Last ingested by Listed: Nov 2, 2026, 20:24 ET. No prices; not investment advice.